Emil Pot

Emil Pot is the Co-Founder and CEO of Allero Therapeutics, a company that develops immunotherapies for allergic and autoimmune disease patients. Emil also holds a position in business development at Oncode Institute, an independent research institute focused on cancer research. Prior to this, Emil worked as a European Patent Attorney and in business development at NLO, a firm specializing in intellectual property. Emil was also a Co-Founder and General Counsel at ActoGeniX N.V. before its successful acquisition. With a background in law and patents, Emil has extensive experience in business development, patent law, and technology transfer.